References:
1. Worldometer. COVID-19 Coronavirus Pandemic updated 04 May 2021.
Available from: https://www.worldometers.info/coronavirus/.
2. COVID-19 Vaccine Tracker. 2021;
https://www.worldometers.info/coronavirus/
Accessed on 01/05/2021.
3. Pfizer and BioNTech Request Regulatory Agencies Expand Emergency Use
of Their COVID-19 Vaccine to Adolescents (2021).
4. Homaira N, Briggs N, Oei JL, Hilder L, et al. Impact of influenza on
hospitalization rates in children with a range of chronic lung diseases.
Influenza and other respiratory viruses. 2019 ;13:233-9.
5. Vaccine preventable diseases: Information about vaccine preventable
diseases, vaccine and reccomendations fro vaccination from the
Australian Immunisation Handbook Canberra: Australian Government;
Department of Health;
https://immunisationhandbook.health.gov.au/vaccine-preventable-diseases.Accessed
on 01 April 2021
6. Australian Bureau of Statistics (ABS). Socio-Economic Indexes for
Areas (SEIFA) 2016. 2018. Report No.: Cat. No. 2033.0.55.001.
7. Chau JPC, Lo SHS, Choi KC, Chau MHK, et al. Factors determining the
uptake of influenza vaccination among children with chronic conditions.2017 ;36:e197-e202.
8. Smith LE, Amlôt R, Weinman J, Yiend J, Rubin GJ. A systematic review
of factors affecting vaccine uptake in young children. Vaccine.2017 ;35:6059-69.
9. Skjefte M, Ngirbabul M, Akeju O, Escudero D, et al. COVID-19 vaccine
acceptance among pregnant women and mothers of young children: results
of a survey in 16 countries. 2021 ;36:197-211.
10. Smith LE, Amlot R, Weinman J, Yiend J, Rubin GJ. A systematic review
of factors affecting vaccine uptake in young children. Vaccine.2017 ;35:6059-69.
11. Wise J. Covid-19: European countries suspend use of
Oxford-AstraZeneca vaccine after reports of blood clots. the bmj; 2021.
12. Newcombe J, Kaur R, Wood N, Seale H, Palasanthiran P, Snelling TJV.
Prevalence and determinants of influenza vaccine coverage at tertiary
pediatric hospitals. 2014 ;32:6364-8.
13. Mahase E. AstraZeneca vaccine: Blood clots are “extremely rare”
and benefits outweigh risks, regulators conclude. thebmj; 2021.